Profile
Ronald D.
Seidel was the founder of Cue Biopharma, Inc., founded in 2014, and served as Senior Scientific Advisor from 2021 to 2022.
Dr. Seidel is also the founder of Crosslink Therapeutics, Inc...
Former positions include Associate Director at Albert Einstein College of Medicine, Inc. from 2008 to 2015, and Associate Director-Eukaryotic Protein Production at Northeast Biodefense Center from 2008 to 2013.
Education includes a doctorate conferred in 2005 and an undergraduate degree conferred in 1998, both from the University of Georgia.
Ronald Seidel active positions
| Companies | Position | Start |
|---|---|---|
Crosslink Therapeutics, Inc.
Crosslink Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics medicines | Founder | - |
Former positions of Ronald Seidel
| Companies | Position | End |
|---|---|---|
| CUE BIOPHARMA, INC. | Founder | 01/09/2022 |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/06/2015 |
Northeast Biodefense Center
Northeast Biodefense Center Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in infectious diseases | Corporate Officer/Principal | - |
Training of Ronald Seidel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Northeast Biodefense Center
Northeast Biodefense Center Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in infectious diseases | Commercial Services |
Crosslink Therapeutics, Inc.
Crosslink Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics medicines | Health Technology |
- Stock Market
- Insiders
- Ronald Seidel
















